Sites and patients have complicated views on telehealth in trials. Here’s what the evidence shows about who benefits, who bears the burden, and where the limits are.
- Enabling Cloud Computing In DCTs For Remote Data Capture, Monitoring, And More (Part 1)
- Safe And Sustainable DCTs and Hybrid Trials (Part 2)
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- How To Operationalize AI-Enabled eTMF Systems Under The EU AI Act (Part 2)
- How AI-Enabled eTMF Systems Are Impacted By The EU AI Act (Part 1)
- Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
ON-DEMAND WEBINARS
Discover how a no-code solution transforms insight generation from weeks to minutes. Learn to run analyses, test hypotheses, and enhance patient trial recruitment and diversity with ease.
Take a deep dive into the current system and database utilized in Japan and delve into tips for database selection and how it should be selected according to target disease area and desired result.
Did you know that the average cost for a delayed trial is between $600,000 and $8 million per day? Discover how electronic consent management technology is helping sponsors, CROs, and sites.
Digital health technologies can unlock meaningful insights. Explore the synergy between this cutting-edge technology and managing heart failure, and how it's paving the way for better patient care.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![APPROVED Rubber Stamp iStock-1178959563]( "Driving Successful Obesity Drug Development With GLP-1 Agonists")
Driving Successful Obesity Drug Development With GLP-1 AgonistsGLP-1 agonists are revolutionizing obesity treatment. Signant Health's ePRO solutions support over 30 trials, providing critical patient data and driving successful approvals.
-
![GettyImages-1311429557-vaccine-shot]( "eTMF Systems Tell Compelling Story Of COVID-19 Vaccines")
eTMF Systems Tell Compelling Story Of COVID-19 VaccinesThe rapid development of Covid-19 vaccines may lead more drug developers to increase their speed and agility by adopting electronic Trial Master File (eTMF) systems. In the case of Covid-19 vaccines, discover how eTMF systems tell a dramatic tale.
-
![GettyImages-1474595785 AI]( "Moving Towards AI, ML, And Trial Platforms For True Scalability")
Moving Towards AI, ML, And Trial Platforms For True ScalabilityUncover why AI, ML, and clinical trial platforms have the potential to create true scalability across an organization's entire pipeline, and reduce timelines by YEARS.
-
![GettyImages-1185375119 data collection]( "How Efficiencies In Trial Builds Facilitate Quicker Data Collection")
How Efficiencies In Trial Builds Facilitate Quicker Data CollectionDiscover how the integration of EDC technology benefits researchers and can hasten treatment and therapy development, improving the lives of patients.
-
![GettyImages-1142528978 digital healthcare]( "Embracing Accessibility: The Future Of Clinical Trials")
Embracing Accessibility: The Future Of Clinical TrialsExplore the reasons why accessibility stands as a crucial pillar for the prosperity of biopharmaceutical and clinical research, having evolved into an all-encompassing industry imperative.
-
![GettyImages-1443965506 doctor clinical trial data monitoring]( "What Is The Suvoda Platform?")
What Is The Suvoda Platform?If you're ready to streamline your clinical trials and deliver better outcomes for all stakeholders, explore how the Suvoda Platform can transform your trial experience today.
-
![GettyImages-1204781345 doctor tablet meeting]( "QT Monitoring Impacts More Than Just Cardiac Health")
QT Monitoring Impacts More Than Just Cardiac HealthAchieve earlier detection of potential adverse cardiac events and refine patient selection for future trial phases by implementing advanced QT monitoring tools.
-
![GettyImages-1281389422 AI]( "Responsible Use Of AI In Healthcare: Work In Progress")
Responsible Use Of AI In Healthcare: Work In ProgressDelve into the transformative role and potential benefits of artificial intelligence (AI) in healthcare and learn why it's crucial to carefully consider and plan for the responsible use of AI.
-
![scientist lab research data laptop iStock-589973864]( "Visual Analytics And Discovery Platform For Scientific And Clinical R&D")
Visual Analytics And Discovery Platform For Scientific And Clinical R&DA pharmaceutical company was looking to deploy a software solution for a small R&D group. See how an enterprise-class visualization and analytics platform enabled maximized understanding of research data.
-
![GettyImages-1938542776 doctor patient]( "Why Real-Time eCOA Data Matters More Than Ever")
Why Real-Time eCOA Data Matters More Than EverReal-time eCOA data enables faster eligibility decisions, proactive issue alerts, and streamlined operations by unifying data, improving precision, responsiveness, and trial execution efficiency.
FROM THE EDITOR
- Telehealth In Clinical Trials: What Sites And Patients Think
- Telehealth In Clinical Trials: What You Need To Know
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
RECENT NEWSLETTERS
- 03.07.26 -- February's Best In Clinical Tech — AI, eTMF & More
- 03.05.26 -- Is Your Legacy EDC Holding Back AI In Clinical Trials?
- 02.26.26 -- EU AI Act Compliance For eTMF Systems: What Clinical Tech Leaders Need To Know
- 02.19.26 -- The Clinical Tools Quietly Reshaping Trial Operations
- 02.12.26 -- How Can AI Change Computerized System Validation?
